These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8503430)

  • 21. Renal hemodynamic effects of calcium antagonists.
    Loutzenhiser RD; Epstein M
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S48-52. PubMed ID: 2468906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Wakino S; Saruta T
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):243-7. PubMed ID: 10028932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the renal effects of calcium antagonists.
    Ruilope LM; Lahera V; Rodicio JL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S49-53. PubMed ID: 7609506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity.
    Seyss C; Foote EF
    Ann Pharmacother; 1995 Feb; 29(2):187-8. PubMed ID: 7756720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K; Ozawa Y; Fujiwara K; Wakino S; Kumagai H; Saruta T
    Am J Nephrol; 2003; 23(4):229-44. PubMed ID: 12840599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Hayashi K; Ozawa Y; Wakino S; Kanda T; Homma K; Takamatsu I; Tatematsu S; Saruta T
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):697-702. PubMed ID: 14639089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists and renal protection.
    Neumayer HH; Gellert J; Luft FC
    Ren Fail; 1993; 15(3):353-8. PubMed ID: 8516490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
    Rodicio JL
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S7-11. PubMed ID: 11347860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephro-protective effect of calcium antagonists].
    Deray G
    Presse Med; 1999 Oct; 28(30):1667-70. PubMed ID: 10544702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of calcium antagonists: past, present, and future.
    Messerli FH
    Clin Cardiol; 2003 Feb; 26(2 Suppl 2):II12-6. PubMed ID: 12622321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium antagonists and the kidney.
    Pearce CJ; Wallin JD
    New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcium channel blockers on renal function.
    Chan L; Schrier RW
    Annu Rev Med; 1990; 41():289-302. PubMed ID: 2184731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy.
    Epstein M
    Ren Fail; 1996 Nov; 18(6):813-32. PubMed ID: 8948517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiocontrast-induced nephropathy.
    Asif A; Preston RA; Roth D
    Am J Ther; 2003; 10(2):137-47. PubMed ID: 12629594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal protection with calcium antagonists: the role of lercanidipine.
    Burnier M
    Curr Med Res Opin; 2013 Dec; 29(12):1727-35. PubMed ID: 24069902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempts to improve the selectivity of calcium antagonistic drugs.
    van Zwieten PA; Pfaffendorf M; Mancia G
    Blood Press Suppl; 1996; 5():7-9. PubMed ID: 8973786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of hypertension with calcium antagonists. Heart and kidney protection for elderly type 2 diabetic patients].
    Keil TU
    MMW Fortschr Med; 2000 Mar; 142(11):18. PubMed ID: 10786084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.